U.S. insulin costs per patient nearly doubled from 2012 to 2016, study finds
The cost of insulin for treating Type 1 diabetes in the United States nearly doubled over a recent five-year period, underscoring a national outcry over rising drug prices, according to a new analysis.
A patient with Type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that, at $2,864 per patient, in 2012, according to a report released on Tuesday by the nonprofit Health Care Cost Institute.
The figures represent the combined amount paid by a patient and their health plan for the medicine and do not reflect rebates paid at a later date.
(Score: 2) by dry on Thursday January 24 2019, @06:33AM (1 child)
You still get the exploitative pharmaceutical industry, though you might have the buying power to make a difference. Here in Canada, drugs cost a fortune as each Province/Territory negotiates separately.
(Score: 2) by PartTimeZombie on Thursday January 24 2019, @06:34PM
That's true, they are exploitative. We have a national drug buying agency, and surprise surprise our American friends were very keen to hobble it during the TPP negotiations.